Advanced search

Instruments

	Name		Stock exchange	Average volume	Price	Type
	MANABE INTERIOR HEARTS CO., LTD.	7113	Japan Exchange	0	450 JPY	Stock

News (128)

Transcript : Daiichi Sankyo Company, Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 01:30 PM	01-08
Daiichi Sankyo : Value Report 2023 (10.1MB)	23-10-31	PU
Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs	23-10-19	BU
Transcript : Daiichi Sankyo Company, Limited - Analyst/Investor Day	23-06-05
Daiichi Sankyo : Announces Appointments of Directors and Audit & Supervisory Board Members(265.9KB	23-05-16	PU
Daiichi Sankyo : Announces Appointment of CxOs(129.8KB	23-03-30	PU
Transcript : Daiichi Sankyo Company, Limited - Special Call	23-03-14
Daiichi Sankyo Company, Limited Appoints Hiroyuki Okuzawa as New President & COO Effective as of April 1, 2023	23-01-30	CI
Transcript : Daiichi Sankyo Company, Limited - Special Call	23-01-17
Transcript : Daiichi Sankyo Company, Limited Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 08:15 AM	23-01-09
Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging	22-12-21	PR
IFPMA President and CEO of UCB, Jean-Christophe Tellier welcomes Sunao Manabe, President and CEO of Daiichi Sankyo to IFPMA leadership team	22-12-16	AQ
Transcript : Daiichi Sankyo Company, Limited - Special Call	22-12-12
Arbitrator Rules in Favor of Daiichi Sankyo in Dispute with Seagen	22-08-12	BU
Daiichi Sankyo : Consolidated Financial Results for the First Three Months of the Year Ending March 31,2023	22-07-29	PU
Daiichi Sankyo : Announces Completion of Payment Concerning Disposal of Treasury Shares as Restricted Share-Based Compensation	22-07-26	PU
Transcript : Daiichi Sankyo Company, Limited - Special Call	22-06-07
Daiichi Sankyo : Consolidated Financial Results for Year Ended March 31, 2022	22-04-27	PU
Daiichi Sankyo : FY2021 Financial Results Presentation	22-04-27	PU
Daiichi Sankyo : Consolidated Financial Results for the First Nine Months of the Year Ending March 31,2022	22-01-30	PU
Transcript : Daiichi Sankyo Company, Limited - Special Call	21-12-14
Daiichi Sankyo : "R&D Day 2021"	21-12-14	PU
Transcript : Daiichi Sankyo Company, Limited - Analyst/Investor Day	21-11-19
Transcript : Daiichi Sankyo Company, Limited - Special Call	21-10-29
Daiichi Sankyo : Corporate Governance Report	21-10-11	PU
Daiichi Sankyo : Consolidated Financial Results for the First Three Months of the Year Ending March 31,2022	21-07-30	PU
Daiichi Sankyo : Corporate Governance Report	21-06-22	PU
Transcript : Daiichi Sankyo Company, Limited - Special Call	21-06-08
Daiichi Sankyo : Announces the Introduction of a Trust-type Share-based Compensation System for its Directors, etc.	21-05-13	PU
Daiichi Sankyo : Announces Changes to Representative Directors, Directors and Audit & Supervisory Board Members	21-05-13	PU
Transcript : Daiichi Sankyo Company, Limited - Special Call	21-04-05
Alfresa : Notice regarding Transfer of 11 Long-listed products from Daiichi Sankyo	21-02-25	PU
Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D	21-02-22	BU
ENHERTU® Receives Prime Minister’s Award from the Japan Techno-Economics Society	21-01-27	BU
Transcript : Daiichi Sankyo Company, Limited Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05:20 AM	21-01-13
Transcript : Daiichi Sankyo Company, Limited - Special Call	20-12-15
Daiichi Sankyo : Creates New Business Unit to Unify Major Oncology Markets into One Streamlined Organization Dedicated to Patients with Cancer	20-11-16	AQ
Daiichi Sankyo : Creates New Business Unit to Unify Major Oncology Markets into One Streamlined Organization Dedicated to Patients with Cancer	20-11-12	BU
Transcript : Daiichi Sankyo Company, Limited, Q2 2021 Earnings Call, Oct 30, 2020	20-10-30
Daiichi Sankyo : and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo's ADC DS-1062	20-07-28	AQ
Daiichi Sankyo : and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062	20-07-27	BU
Nichi Iko Pharmaceutical : The University of Tokyo, RIKEN, Nichi-Iko and Daiichi Sankyo Reach Basic Agreement on Collaborative R&D on Nafamostat Inhalation Formulation	20-06-09	AQ
Transcript : Daiichi Sankyo Company, Limited - Special Call	20-06-02
Daiichi Sankyo : Mitsubishi UFJ Capital and Nagoya Institute of Technology Announce Open Innovation Research on Gene Therapy to Restore Vision	20-04-14	AQ
Transcript : Daiichi Sankyo Company, Limited - Special Call	19-12-19

1234NextSee all

Companies (1)

MANABE INTERIOR HEARTS CO., LTD. 24 M $

Manabe Interior Hearts Co Ltd is a Japan-based company mainly engaged in furniture and home fashion businesses. The Company is mainly engaged in the sale of furniture, interior goods, daily necessities, household goods and others through stores. The Compa ...

Insiders

Sunao Manabe

Sunao Manabe is President, CEO & Representative Director at Daiichi Sankyo Co., Ltd.

Sunao Aoki

Sunao Aoki is currently working as a Director at DKS Co., Ltd.
He previously worked as a Representative Director & SEVP at Mitsubishi Heavy Industries, Ltd.

Sunao Yamashita

Sunao Yamashita served as the Chairman of DKK-TOA Corp.
from 2000 to 2011.

No results for this search